2025 ACI: SIO

ACI

thursday, june 5, 2025 | 8 A.m.–12 p.m. CT
Chicago, IL

Register Now

This Advances in Cancer Immunotherapy (ACI) program will be held in person at the University of Chicago Gleacher Center in Chicago, IL, in conjunction with the Society of Interventional Oncology (SIO)’s Multidisciplinary NEXT Summit: Novel Explorations in Combination Therapies.

The 2025 Advances in Cancer Immunotherapy™ series is supported, in part, through independent medical education grants from AstraZeneca, GSK, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., and Replimune Inc. (supporters as of Apr. 1, 2025).

Program Organizers

Richard Finn, MD
UCLA

Robert Lewandowski, MD, FSIR
Northwestern University Feinberg School of Medicine

Program Snapshot

Credits Available
Physician Education: 3.75 contact hours
Pharmacy Education: 3.75 contact hours (0.375 CEUs)
Nursing Education: 3.75 contact hours

Program Date & Location

Thursday, June 5, 2025 at 8 A.M.–12 P.M. CT
Chicago, IL

Register for ACI Session at the Society of Interventional Oncology (SIO)'s Multidisciplinary NEXT Summit >

Program Agenda

8–8:05 a.m.

 

Welcome

8:05–8:25 a.m.

 
Interventional Oncology: From A to Y (ablation to Y 90)
Robert Lewandowski, MD, FSIR – Northwestern University Feinberg School of Medicine

8:25–8:55 a.m.

  
History of Immuno-Oncology: How Did We Get Where We Are 
Tak Mak, PhD, FAIO – Princess Margaret Cancer Centre at University Health Network

8:55–9:15 a.m.

 
Intersection of Immuno-Oncology and IO
Rahul Sheth, MD – The University of Texas MD Anderson Cancer Center

9:15–9:35 a.m.

 
How are we doing? Review of the Level 1 Evidence
Adam Burgoyne, MD, PhD – UC San Diego

9:35–9:55 a.m.

 

Filling the Gaps - Where Do We Go from Here?
Richard Finn, MD – UCLA

9:55–10:05 a.m.

 
Discussion and Q&A

10:05–10:20 a.m.

 

Break

10:20–10:30 a.m.

 

The Apscopal Effect: Is It Real?
Tim Greten, MD – National Institutes of Health

10:30–10:40 a.m.

 

Assessing Response to IO and LRT: RECIST, mRECIST, irRECIST, and More
Beau Toskich, MD – Mayo Clinic

10:40–10:50 a.m.

 

Patient Hurdles and How to Overcome
Sarah Manes – Global Liver Institute

10:50–11:00 a.m.

 

Discussion and Q&A

11:00 a.m.– 12:00 p.m.

 

Faculty Panel

12 p.m.

 

Closing Remarks

SITC ACI Series

This program is part of the SITC ACI series. View below to explore more programs in the 2025 ACI series.

Program Details

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Case Study Submission Information

As part of the program, registrants are encouraged to submit case studies for expert review during the case study panel concluding the program. If you are interested in taking advantage of this opportunity, please review and sign the linked case study guidelines, and return your case study and signed guidelines to education@sitcancer.org.

 

Accreditation Information

Joint Accreditation Statement

thumbnail image In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Society for Immunotherapy of Cancer (SITC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)

ABIM_Logo.jpgSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Continuing Medical Education

PACE designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

PACE designates this continuing education activity for 3.75 contact hour(s) (0.375 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Nursing Education

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

Disclosures

Disclosure of Conflicts of Interest

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Avoid Fraudulent ACI Websites

Recently, the SITC office received communication about a fraudulent registration website for one of our ACI programs. To help ensure others don’t mistakenly register on an unauthorized, third-party website, we're proactively informing you to ensure you’re able to safely register for the event through the official SITC website, and so that you can confirm the communication you receive is truly from SITC.

All official forthcoming ACI registration information will come from an email address ending in @sitcancer.org. If you have any questions, please contact the SITC office at events@sitcancer.org or 414-271-2456.